I would have said the same thing.
I would add that, unfortunately, the big pharmaceutical companies have little incentive to develop new antibiotics. It is a very complex and very competitive market.
So we have to rely on the research done by universities which, however, depends on government and federal funding. That funding must therefore be sufficient, especially for research and development of new antibiotics.